BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24157256)

  • 21. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
    Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Karkantaris C; Anargyrou K; Boutsis DE; Variamis E; Michalopoulos T; Boussiotis VA; Panayiotidis P; Papavassiliou C; Pangalis GA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):765-81. PubMed ID: 15183480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group.
    Schellong G; Dörffel W; Claviez A; Körholz D; Mann G; Scheel-Walter HG; Bökkerink JP; Riepenhausen M; Lüders H; Pötter R; Rühl U;
    J Clin Oncol; 2005 Sep; 23(25):6181-9. PubMed ID: 16135485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
    Hakvoort-Cammel FG; Buitendijk S; van den Heuvel-Eibrink M; Hählen K
    Pediatr Blood Cancer; 2004 Jul; 43(1):8-16. PubMed ID: 15170884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
    Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin disease.
    Wendland MM; Asch JD; Pulsipher MA; Thomson JW; Shrieve DC; Gaffney DK
    Am J Clin Oncol; 2006 Apr; 29(2):189-95. PubMed ID: 16601441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
    J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The management of children with lymphomas.
    Frew JA; Lewis J; Lucraft HH
    Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):11-8. PubMed ID: 23231943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in Hodgkin lymphoma.
    Josting A
    Expert Rev Hematol; 2010 Oct; 3(5):583-92. PubMed ID: 21083475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The results of treatment children's Hodgkin lymphoma at pediatric clinic in Sarajevo].
    Hasanbegović E
    Med Arh; 2005; 59(6):349-50. PubMed ID: 16268060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pediatric Hodgkin disease in south Tunisia: a study of 23 cases].
    Khanfir A; Toumi N; Masmoudi A; Hdiji S; Elloumi M; Makni S; Boudaouara T; Daoud J; Frikha M
    Cancer Radiother; 2007 Sep; 11(5):241-6. PubMed ID: 17611139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.
    Vassilakopoulos TP; Boutsikas G; Papadakis V
    Transl Pediatr; 2013 Jul; 2(3):126-30. PubMed ID: 26835304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality control of involved field radiotherapy in the HD 13 and HD 14 trials : Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG).
    Kriz J; Baues C; Engenhart-Cabillic R; Haverkamp U; Herfart K; Lukas P; Plütschow A; Schmidberger H; Staar S; Fuchs M; Engert A; Eich HT
    Strahlenther Onkol; 2017 Feb; 193(2):109-115. PubMed ID: 27596217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concordance in the interpretation of PET after chemotherapy in advanced stage Hodgkin lymphoma.
    Kobe C; Kuhnert G; Haverkamp H; Fuchs M; Kahraman D; Eich HT; Kriz J; Baues C; Nast-Kolb B; Bröckelmann PJ; Borchmann P; Drzezga A; Engert A; Dietlein M
    Nuklearmedizin; 2015; 54(6):241-6. PubMed ID: 26388152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurological presentation of Hodgkin lymphoma in the Italian Association of Pediatric Hematology and Oncology LH-2004 protocol.
    Burnelli R; Fabbri E; Guerrini G; Sperlì D; D'ambrosio A
    Leuk Lymphoma; 2011 Jun; 52(6):1049-54. PubMed ID: 21534870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Early-stage Hodgkin Lymphoma: A Practice Guideline.
    Herst J; Crump M; Baldassarre FG; MacEachern J; Sussman J; Hodgson D; Cheung MC
    Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):e5-e12. PubMed ID: 27697411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer/Lymphoma Study Association/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons Learned.
    Aleman BMP; Ricardi U; van der Maazen RWM; Meijnders P; Beijert M; Boros A; Izar F; Janus CPM; Levis M; Martin V; Specht L; Corning C; Clementel E; Raemaekers JM; André MP; Federico M; Fortpied C; Girinsky T
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):664-674. PubMed ID: 37179034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.
    Giulino-Roth L; Keller FG; Hodgson DC; Kelly KM
    Br J Haematol; 2015 Jun; 169(5):647-60. PubMed ID: 25824371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012).
    Townsend W; Leong S; Hoskin P; Diez P; Patrick P; Linch D; Wong WL; Kayani I; Sanghera B; Lopes A; Daw S; Collins G; Clifton-Hadley L; Ardeshna K
    Br J Haematol; 2020 Apr; 189(1):128-132. PubMed ID: 31710702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The EuroNet paediatric hodgkin network - modern imaging data management for real time central review in multicentre trials.
    Kurch L; Mauz-Körholz C; Bertling S; Wallinder M; Kaminska M; Marwede D; Tchavdarova L; Georgi TW; Elsner A; Barthel A; Stoevesandt D; Hasenclever D; Sattler B; Sabri O; Körholz D; Kluge R
    Klin Padiatr; 2013 Nov; 225(6):357-61. PubMed ID: 24166093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.